Below is the Youtube link for ID-IRI introductory video. You can enjoy the movie
Anxiety in physicians for COVID-19
The aim of this survey is to determine the anxiety status of physicians for COVID-19. We will try to detail the tough points that the medical doctors face in the management of the current pandemic. Hopefully, your feedback in this survey will enhance the supportive mechanisms for the medical staff.
Please kindly click the link below and submit your answers. Thank you for your participation
ID-IRI Infections in the Emergency Departments Survey
We are receiving many emails for deadline extension for the data submission of “ID-IRI Infections in the Emergency Departments Survey”. Since the centers facing the coronavirus pandemic are stretched with the heavy workload we will extend the deadline.
The updated deadline for data submission is March 20, 2020, for your information.
ID-IRI Anthrax and Candida auris Surveys, closed
ID-IRI Anthrax and Candida auris Surveys are closed. We will analyze the databases, and hopefully, we will try to provide inferences in the management of these two distinct diseases.
Many thanks to all participating centers.
ID-IRI Acineto VAP paper published and paginated
Hakan Erdem, Yasemin Cag, Serap Gencer, Serhat Uysal, Zuhal Karakurt, Rezan Harman, Emel Aslan, Esmeray Mutlu-Yilmaz, Oguz Karabay, Yesim Uygun, Mehmet Ulug, Selma Tosun, Arzu Dogru, Alper Sener, Mustafa Dogan, Rodrigo Hasbun, Gul Durmus, Hale Turan, Ayse Batirel, Fazilet Duygu, Asuman Inan, Yasemin Akkoyunlu, Guven Celebi, Gulden Ersoz, Tumer Guven, Ozgur Dagli, Selma Guler, Meliha Meric-Koc, Serkan Oncu, Jordi Rello.
Treatment of ventilator-associated pneumonia (VAP) caused by Acinetobacter: Results of prospective and multicenter ID-IRI study. European Journal of Clinical Microbiology & Infectious Diseases 2020; 39: 45–52
The diagnostic utility of the Lancet and Thwaites Criteria in Tuberculous vs. Non-tuberculous Subacute Meningitis: Multicenter Analysis of 395 adult patients
“The diagnostic utility of the Lancet and Thwaites Criteria in Tuberculous vs. Non-tuberculous Subacute Meningitis: Multicenter Analysis of 395 adult patients” was previously submitted to BMC Infectious Diseases. The journal asks revision of the paper. We will do our best FYI.
List of Authors
Tarek Sulaiman; Sai Medi; Hakan Erdem; Seniha Senbayrak; Derya Ozturk-Engin; Asuman Inan; Rok Civljak; Mihai Nechifor; Ayhan Akbulut; Alexandru Crisan; Muge Ozguler; Mustafa Namiduru; Branislava Savic; Olga Dulovic; Filiz Pehlivanoglu; Gonul Sengoz; Kadriye Yasar; Ayse Seza Inal; Emine Parlak; Isik Somuncu Johansen; Ebru Kursun; Mehmet Parlak; Emel Yilmaz; Gulden Yilmaz; Hanefi Cem Gul; Oral Oncul; Soline Siméon; Pierre Tattevin; Aysegul Ulu-Kilic; Selma Alabay; Bojana Beovic; Melanie Catroux; Yves Hansmann; Arjan Harxhi; Alper Sener; Hacer Deniz Ozkaya; Yasemin Cağ; Canan Agalar; Haluk Vahaboglu; Berna Kaya Ugur; Rodrigo Hasbun
Prospective ID-IRI Sepsis study, accepted for publication
A NOVEL ID-IRI SCORE: DEVELOPMENT AND INTERNAL VALIDATION OF THE MULTIVARIABLE COMMUNITY ACQUIRED SEPSIS CLINICAL RISK PREDICTION MODEL has been accepted for publication in European Journal of Clinical Microbiology & Infectious Diseases. We developed a simplified and easy to use prognostic score for COMMUNITY ACQUIRED SEPSIS PATIENTS named as CAS. I am pleased to tell you that CAS predicts mortality better than APACHE scoring system. I would like to thank Dr Husrev Diktas and Dr. Serhat Uysal for their great contributions to the study.
The patients’ data comes from centers in Albania, Bosnia and Herzegovina, France, Egypt, Hungary, Italy, Kazakhstan, North Macedonia, Puerto Rico, Romania, Saudi Arabia, Serbia, Turkey, USA.
Many thanks to our group
Author List
Husrev Diktas; Serhat Uysal; Hakan Erdem; Yasemin Cag; Egidia Miftode; Gul Durmus; Ayşegul Ulu-Kilic; Selma Alabay; Balint Gergely Szabo; Botond Lakatos; Ricardo Fernandez; Pinar Korkmaz; Michael Cruz Caliz; Xavier Argemi; Sholpan Kulzhanova; Fatime Kormaz; Fatma Yilmaz-Karadag; Rodrigo Hasbun; Pinar Karagoz-Ergen; Aynur Atilla; Edmond Puca; Mustafa Dogan; Francesca Mangani; Suzan Sahin; Svjetlana Grgić; Krsto Grozdanovski; G. Ruhsar Yilmaz, Rosa Fontana Del-Vecchio; Aslihan Demirel; Fatma Sirmatel Alper Şener; Suzan Sacar; Emsal Aydin; Ayşe Batirel; Gorana Dragovac; Rehab El-Sokkary; Crişan Alexandru; Selcan Arslan-Ozel; Sibel Bolukcu; H. Deniz Ozkaya; Saygin Nayman-Alpat; Asuman Inan; Fahad Al-majid; Berna Kaya-Ugur; Jordi Rello.
Neuroinvasive WNV disease study accepted for publication
We are pleased to say that ID-IRI study analyzing neuroinvasive West Nile virus infections is provisionally accepted for publication in the Journal of Clinical Virology. The journal asks for minor revision. Thanks to the Roman team, Dr. Corneliu Popescu and Simin Aysel Florescu in particular, in finalizing the entire process and many thanks to the ID-IRI platform.
Author List
Corneliu Petru Popescu, Simin Aysel Florescu, Rodrigo Hasbun, Arjan Harxhi, Razi Evendar, Hasip Kahraman, Ami Neuberger, Daniel Codreanu, Mihaela Florentina Zaharia, Selma Tosun, Emanoil Ceausu, Simona Maria Ruta, Gorana Dragovac, Natalia Pshenichnaya, Galina Gopatsa, Olga Shmaylenko, Éva Nagy, Jelena Djekic Malbasa, Mirjana Strbac, Nenad Pandak, Husnu Pullukcu, Botond Lokotos, Yasemin Cag, Antonio Cascio, Ilaria Coledan, Serkan Oncu, Hakan Erdem
ID-IRI Acinetobacterial VAP study
ID-IRI study “Treatment of ventilator-associated pneumonia (VAP) caused by Acinetobacter: results of prospective and multicenter ID-IRI study” is published online in European Journal of Clinical Microbiology and Infectious Diseases. Thanks to all participants. Please see the link below
ID-IRI survey for MDR organisms, IPC and antibiotic stewardship issues
We have previously announced ID-IRI survey targeting MDR organisms, IPC and antibiotic stewardship issues. It is to start within a couple of weeks for your information. The study will focus on
1. Antibiotic susceptibility profiles of infecting pathogens
2. Infection Prevention & Control capabilities
3. Antibiotic stewardship infrastructure
2. Infection Prevention & Control capabilities
3. Antibiotic stewardship infrastructure
We will send the application form to sign and return the scanned document to us via email.
